PEAK6 Group’s DexCom DXCM Stock Holding History

PEAK6 Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-232,412	Closed	-$2.84M	–	4240
2017 Q3	$2.84M	Buy	232,412 +223,512	+2,511%	+$3.95M	0.01%	1119
2017 Q2	$163K	Buy	+8,900	New	+$164K	﹤0.01%	3528
2017 Q1	–	Sell	-37,700	Closed	-$736K	–	4437
2016 Q4	$563K	Buy	+37,700	New	+$668K	﹤0.01%	2399
2016 Q2	–	Sell	-21,560	Closed	-$367K	–	4382
2016 Q1	$366K	Sell	21,560 -2,852	-12%	-$47.6K	﹤0.01%	2571
2015 Q4	$500K	Sell	24,412 -201,452	-89%	-$4.19M	﹤0.01%	2587
2015 Q3	$4.85M	Buy	+225,864	New	+$5.04M	0.03%	921
2015 Q1	–	Sell	-20,332	Closed	-$307K	–	4843
2014 Q4	$280K	Buy	+20,332	New	+$249K	﹤0.01%	3089
2014 Q3	–	Sell	-46,388	Closed	-$460K	–	4760
2014 Q2	$460K	Sell	46,388 -92,820	-67%	-$822K	﹤0.01%	2384
2014 Q1	$1.44M	Buy	+139,208	New	+$1.44M	0.01%	1543

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PEAK6 Group's DXCM Position: Q4 2017 in Review

PEAK6 Group sold out of DexCom (DXCM) in Q4 2017, closing a stake of 232,412 shares — an estimated $2.84M sold.

PEAK6 Group first reported a position in DXCM in Q1 2014 and held it in 9 quarters. The position peaked at $4.85M in Q3 2015. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

PEAK6 Group reported no remaining DexCom position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 232,412 DexCom shares in Q4 2017, an estimated $2.84M.
PEAK6 Group first reported a position in DexCom in Q1 2014 and held it in 9 quarters.
PEAK6 Group's DexCom position peaked at $4.85M in Q3 2015.
273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.